The MCL31 Dermablate Erbium:YAG laser ablates the skin with a degree of precision that can be measured in microns and can be carried out as a fully ablative or fractional process. This allows a safely and gently remove of wide variety of lesions from the skin at epidermis and dermis level and an effective ablative skin resurfacing. Its reliability and effectiveness have been proven worldwide.
The wavelength of 2,940 nm of the Erbium laser matches the maximum peak of water absorption (water is the main component of the skin). The energy is therefore entirely used for the rapid vaporization of the water in the tissue, which leads to the almost instant ablation of tissue. Due to its characteristics, the MCL31 Dermablate has a significantly shorter healing time compared to a CO2 laser (time for re-epithelialization, erythema, edema). On the other hand, the CO2 laser results in better hemostasis thanks to coagulation.
Thanks to the greatly limited thermal effects of the Erbium laser, the procedure is less painful than with CO2 lasers. Patients do not require any anesthesia in the treatment of small lesions. Side effects and risks are greatly reduced with this laser. The safety of this treatment makes the Erbium laser the superior choice for delicate areas such as the periorbital region or even the neck, chest and hands.
The patented handpiece design guarantees an effective and simultaneous aspiration of the ablated particles, at the same time as the emission of the laser light is activated by the footswitch. No additional switch is needed and noise is kept to a minimum. This also means that physicians no longer have to purchase a supplementary device or have an assistant present to hold it during treatment.
Another Asclepion innovation is the ease with which physicians can now vary the spot size (from 1 to 6mm), simply by turning a ring on the handpiece. The machine automatically recognizes the change and the laser is immediately ready for use, ensuring considerable time savings and a high degree of user-friendliness.
The MCL31 Dermablate is the first Erbium:YAG laser to allow the pulse length to be changed. Thanks to this feature you can work with both extremely short pulses, which guarantee a highly precise “cold ablation”, and with longer pulses “hot ablation” (up to 1000 ms) for a thermal effect on the tissue. The “cold ablation” is particularly suited for purely ablative treatments (for example for the removal of dermal and epidermal lesions) while the “hot ablation” is recommended for rejuvenation treatments, as it effectively stimulates neocollagenesis. The two modes can also be combined, for example in removal of lesions located in the dermis (coagulation mode).
Thanks to the thermal mode, the laser MCL31 Dermablate offers the ability to limit any bleeding during ablation treatments with a simple gesture. With this function it is possible to change the mode on the work screen from ablative to thermal in an instant; this causes an instantaneous coagulation and allows the physician to curbing pinpoint bleeding that can occur when working in the deeper layers of the dermis (e.g. in the removal of dermal lesions). In this way the treatment area remains clean and visible during the entire treatment, allowing the operator to work quickly, safely and effectively.
The clear and sharp display with touch-sensitive buttons and a user-friendly interface allows an intuitive and pleasant working environment for an optimum treatment procedure. The three treatment modes (Ablation, Therm, MicroSpot) are optimized specifically for the applications.
The MCL31 Dermablate can be upgraded with the following optional items:
In addition to the standard handpiece, you can also choose the VarioTEAM XL Handpiece, which allows you to adjust the spot sizes starting from 8 up to 12mm – for the rapid treatment of larger lesions.
The MicroSpot handpiece features a special microlens array with a 13 x 13 mm spot (169 MicroSpots) and is used for fractional skin ablation treatments, such as fractional skin rejuvenation. This optic allows the selective treatment of only “fractions” of the tissue in the form of a grid. This is made possible by splitting the laser beam into several hundred partial rays. This triggers skin renewal and collagen formation with rapid wound healing, which is supported by the untreated skin and therefore involves a very low risk of side effects. Thanks to an exclusive microlens array, the MicroSpot technology provides a unique level of precision. The cover rate can be set directly on the handpiece by rotating the ring. This increases flexibility and enables even better treatment results in fractional laser therapy.
The CUT handpiece extends the application range of the MCL31 Dermablate and offers for the first time worldwide the possibility of cutting with an Er:YAG laser.
The MCL31 Dermablate is the first laser to feature a special footswitch that allows the physician to adjust the fluence/the repetition rate without the need to touch the device screen, to ensure an efficient workflow.
